Censa Pharmaceuticals' Unattributed Round

Censa Pharmaceuticals raised a round of funding on April 19, 2016.

Censa Pharmaceuticals primary focus is the development and commercialization of therapeutics for (ultra) orphan CNS disorders. The company is collaborating with world-class thought leaders and patient…

Articles about Censa Pharmaceuticals' Unattributed Round: